Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today they have entered a non-binding Memorandum of ...

The saphenous vein continues to be one of the most commonly used conduits in CABG surgery because it is easy to harvest, readily available, versatile, resistant to spasm, and has been thoroughly ...

Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in ...

These complex lesions may be classified according to anatomic criteria, including extensive calcification, thrombus, and chronic occlusions, or by location, such as bifurcations, saphenous vein ...

More information: Derrick Y Tam et al, Fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting: please mind the gap, The Lancet (2025). DOI: 10. ...